BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6328995)

  • 1. Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary.
    Malkasian GD; Melton LJ; O'Brien PC; Greene MH
    Am J Obstet Gynecol; 1984 Jun; 149(3):274-84. PubMed ID: 6328995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic parameters in patients with advanced ovarian malignant tumors.
    Pohl R; Dallenbach-Hellweg G; Plügge T; Czernobilsky B
    Eur J Gynaecol Oncol; 1984; 5(3):160-9. PubMed ID: 6329760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing survival in carcinoma of the ovary.
    Dyson JL; Beilby JO; Steele SJ
    Br J Cancer; 1971 Jun; 25(2):237-49. PubMed ID: 4329950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic behavior of primary ovarian malignancy.
    Julian CG; Goss J; Blanchard K; Woodruff JD
    Obstet Gynecol; 1974 Dec; 44(6):873-84. PubMed ID: 4373686
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology of borderline ovarian tumors.
    Harlow BL; Weiss NS; Lofton S
    J Natl Cancer Inst; 1987 Jan; 78(1):71-4. PubMed ID: 3025504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of c-erbB-2 and prognosis in ovarian carcinoma. Comparison with histologic type, grade, and stage.
    Singleton TP; Perrone T; Oakley G; Niehans GA; Carson L; Cha SS; Strickler JG
    Cancer; 1994 Mar; 73(5):1460-6. PubMed ID: 7906608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.
    Sorbe B; Frankendal B; Veress B
    Obstet Gynecol; 1982 May; 59(5):576-82. PubMed ID: 7070728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer.
    Barber HR; Sommers SC; Synder R; Kwon TH
    Am J Obstet Gynecol; 1975 Mar; 121(6):795-807. PubMed ID: 1092171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathological assessment of ovarian neoplasms. III: The malignant "epithelial" tumours.
    Russell P
    Pathology; 1979 Jul; 11(3):493-532. PubMed ID: 230444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients].
    Meden H; Marx D; Rath W; Kuhn W; Hinney B; Schauer A
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):667-73. PubMed ID: 1360438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of histologic grading in ovarian carcinoma.
    Decker DG; Malkasian GD; Taylor WF
    Natl Cancer Inst Monogr; 1975 Oct; 42():9-11. PubMed ID: 1234640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of postoperative megavoltage radiotherapy of malignant surface epithelial tumors of the ovary.
    Hintz BL; Fuks Z; Kempson RL; Eltringham JR; Zaloudek C; Williamson TJ; Bagshaw MA
    Radiology; 1975 Mar; 114(3):695-700. PubMed ID: 164041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.
    Simons M; Ezendam N; Bulten J; Nagtegaal I; Massuger L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1208-15. PubMed ID: 25978291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
    Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A detailed study of patients and tumor characteristics of epithelial ovarian cancer in Saudi women.
    Al-Badawi IA; Munkarah AR; Tulbah A; Babic II; Al Husaini H; Ahmad S
    Int J Gynecol Cancer; 2013 Mar; 23(3):456-60. PubMed ID: 23360812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
    Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
    Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.